You are here: Industry Insights > generics

News List

FDA demonizes pharma over generics, but most company reputations can take the blow May 30, 2018
The FDA is taking pharma to the woodshed again, this time over generic drug stalling tactics.
FDA demonizes pharma over generics, but most company reputations can take the blow fiercepharma
May 28, 2018
The FDA is taking pharma to the woodshed again, this time over generic drug stalling tactics. Recently, the agency published an online list of pharma companies that together have racked up 150 complaints from generics makers seeking samples.
New FTC rules hurt M&A prospects for hard-hit generics players fiercepharma
February 27, 2018
The generics sector has been looking to M&A as a way to combat the pricing pressure crushing top lines around the industry. But that strategy just got a whole lot less attractive.
AmerisourceBergen sees end in sight for industrywide generics woes fiercepharma
November 06, 2017
Generic drug prices have continued their downward spiral thanks to pressure from consolidated purchasers. But one distributor sees light at the end of the tunnel.
The top 10 cardiovascular drugs in the world fiercepharma
August 29, 2017
Cardiovascular drugs are tough and expensive to develop, but companies are taking the risk.
Japan's Sawai gets U.S. production with $1B deal for Upsher-Smith generics fiercepharma
June 08, 2017
Japan’s Sawai is following the path trod by other drugmakers with big plans for the U.S., establishing a U.S. manufacturing beachhead by acquiring a U.S. generics operation.
Offense and Defense Change of “Spear” and “Shied” in the Patent Cliff Era en-cphi.cn
May 18, 2017
2011 and 2012 were called “patent cliff” era when the original drugs with annual sales of nearly USD 80 billion became off-patent.
The push towards pure generics: Impact on pharma marketing financialexpress
May 05, 2017
Mala Raj, Senior Pharma Marketing and Medical Consultant at PMS Services contemplates the consequences of the generic push on each of the 7Ps & 7Cs of Marketing and suggests some proactive solutions to adapt in this dynamic environment
CPhI research shows positive growth in biologics and generics sector over the next year biospectrumasia
April 27, 2017
Japan has the world’s third largest pharma industry and traditionally its domestic market has thrived
Sawai Pays $1bn for Generics Biz of Upsher-Smith contractpharma
April 27, 2017
Acquisition marks a major expansion of Sawai's presence in the U.S. market

Previous page 1 2 3 4 5 6 Next page